Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dichlorhydrate de bétahistine |
Is a |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to betahistine (finding) |
Causative agent (attribute) |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betahistine hydrochloride 8mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betahistine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to betahistine (finding) |
Causative agent (attribute) |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine mesilate |
Is a |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine hydrochloride 8mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine hydrochloride 8mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine hydrochloride 8mg tablet (substance) |
Has precise active ingredient |
False |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine mesilate |
Is modification of (attribute) |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
dichlorhydrate de bétahistine |
Is modification of (attribute) |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betahistine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betahistine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Betahistine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |